Article

EXaCT-2: An augmented and customizable oncology-focused whole exome sequencing platform

2025-06-04

Abstract excerpt

<title>Abstract</title> <p>With the rapid advances in cancer research, the list of variants and genes that drive human diseases is constantly expanding. Moreover, the FDA has approved more cancer therapies that incorporate a broader set of genomic features than simple gene variants such as Tumor Mutation Burden (TMB), microsatellite instability status (MSI), and fusion events in gene families such as the NTRK rec...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: b6c0ace2-e8f1-5dc1-a796-a6abd92cabba
DOI: 10.21203/rs.3.rs-6612849/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

EXaCT-2: An augmented and customizable oncology-focused whole exome sequencing platformDOI 10.21203/rs.3.rs-6612849/v1Read

EXaCT-2: An augmented and customizable oncology-focused whole exome sequencing platformSemantic proximity Read

Automated next-generation profiling of genomic alterations in human cancers.Semantic proximity Read

Validation of OncoPanel: A Targeted Next-Generation Sequencing Assay for the Detection of Somatic Variants in Cancer.Semantic proximity Read

TruSight Oncology 500: Enabling Comprehensive Genomic Profiling and Biomarker Reporting with Targeted SequencingSemantic proximity Read

An absolute approach to using whole exome DNA and RNA workflow for cancer biomarker testingSemantic proximity Read

A targeted next-generation sequencing panel for identification of clinically relevant mutation profiles in solid tumoursSemantic proximity Read

Exome sequencing reveals comprehensive genomic alterations across eight cancer cell lines.Semantic proximity Read

Development and validation of a whole-exome sequencing test for simultaneous detection of point mutations, indels and copy-number alterations for precision cancer careSemantic proximity Read

Next-Generation Sequencing.Semantic proximity Read

Development and validation of a scalable next-generation sequencing system for assessing relevant somatic variants in solid tumors.Semantic proximity Read

Clinical validation of the tempus xT next-generation targeted oncology sequencing assaySemantic proximity Read

Clinical and Technical Validation of OncoIndx® Assay – A Comprehensive Genome Profiling Assay for Pan-Cancer InvestigationsSemantic proximity Read